Detalhe da pesquisa
1.
Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study.
Eur J Haematol
; 112(3): 379-391, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899734
2.
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
Am J Hematol
; 99(5): 1001-1004, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38404143
3.
Differences between aquagenic and non-aquagenic pruritus in myeloproliferative neoplasms: An observational study of 500 patients.
J Eur Acad Dermatol Venereol
; 37(6): 1175-1183, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808754
4.
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression.
Br J Haematol
; 188(6): 935-944, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31710700
5.
International external quality assurance of JAK2 V617F quantification.
Ann Hematol
; 98(5): 1111-1118, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30535576
6.
A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome.
Eur J Haematol
; 103(2): 137-139, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31102471
7.
Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study).
Haematologica
; 103(4): 607-613, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29246923
8.
Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study.
Haematologica
; 103(3): 438-446, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217781
9.
MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms.
BMC Cancer
; 18(1): 1098, 2018 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30419846
10.
Incidence and impact of atrial arrhythmias on thrombotic events in MPNs.
Ann Hematol
; 97(1): 101-107, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29164292
11.
MYB-GATA1 fusion promotes basophilic leukaemia: involvement of interleukin-33 and nerve growth factor receptors.
J Pathol
; 242(3): 347-357, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28418072
12.
Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms.
Platelets
; 29(7): 723-728, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29090588
13.
Comparison of four methods to assess high-on platelet reactivity under P2Y12 receptor inhibitor.
Platelets
; 29(3): 257-264, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29580115
14.
Sequential analysis of 18 genes in polycythemia vera and essential thrombocythemia reveals an association between mutational status and clinical outcome.
Genes Chromosomes Cancer
; 56(5): 354-362, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27997717
15.
Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis.
Haematologica
; 107(11): 2725-2731, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833299
16.
JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort.
Ann Hematol
; 96(3): 383-386, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27766390
17.
Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis.
Ann Hematol
; 101(4): 893-896, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611719
18.
Genetic differences between paediatric and adult Burkitt lymphomas.
Br J Haematol
; 173(1): 137-44, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26887776
19.
Low incidence of EPOR mutations in idiopathic erythrocytosis.
Haematologica
; 106(1): 299-301, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32165487
20.
CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
J Pathol
; 237(1): 14-24, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25965880